Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Trump may be mystery patient in odd case of 79yo getting experimental obesity drug" is generating significant coverage in the Business category, with 9 articles from 7 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The New Republic, The Daily Beast, Mother Jones and Forbes. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 132d ago.
Quick answers
Why is "Trump may be mystery patient in odd case of 79yo getting experimental obesity dr" trending?
Because 7 independent news sources published 9 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (9)
- Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient The New Republic · 135d ago
- White House Cornered on Identity of Patient, 79, Given Special Weight Loss Drug The Daily Beast · 135d ago
- Did Trump Get Special Access to Retatrutide? Mother Jones · 135d ago
- White House Denies Trump Was Given Exclusive Weight Loss Drug Forbes · 135d ago
- Remember That Time Trump Said He “Probably Should” Take Ozempic? The New Republic · 135d ago
- Lilly allows one-time access to next-gen obesity drug (update) Seeking Alpha · 135d ago
- Lilly’s retatrutide has been offered to a single person via ‘compassionate use’ program statnews.com · 135d ago
- Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it? statnews.com · 135d ago
- Trump may be mystery patient in odd case of 79yo getting experimental obesity drug Ars Technica · 135d ago
Topics
Related trends
AI stocks, oil fall as investors bet on change after US election 'blue wave'
AI and oil stocks decline as investors pivot toward Chinese renewables following a Democratic sweep in the US elections.
Trump's Fed pressure campaign hits a new Democratic wall in the Senate
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Trump approval rating sank as gas prices rose heading into midterms
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
World leaders who sparred with Trump express mix of relief, caution at GOP election rout
World leaders react with a combination of relief and caution following a GOP election rout and the Democratic seizure of the US Congress.
First Lady Melania Trump and LSU Establish $5 Million Fostering the Future Endowment Fund
5 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.
Trump Media’s Shares Fall to Record Low After Midterms
1 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.